BlackRock Advisors’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

BlackRock Advisors’s Portfolio BTX.WS Stock Details BTX.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-49,256	Closed	-$23K	–	3769
2016 Q2	$23K	Sell	49,256 -1,881	-4%	-$1.02K	﹤0.01%	3421
2016 Q1	$31K	Sell	51,137 -1,920	-4%	-$1.3K	﹤0.01%	3319
2015 Q4	$64K	Buy	53,057 +25,438	+92%	+$25.9K	﹤0.01%	3113
2015 Q3	$23K	Buy	27,619 +2,242	+9%	+$2.03K	﹤0.01%	3487
2015 Q2	$29K	Buy	+25,377	New	+$48.7K	﹤0.01%	3416

Other funds holding BTX.WS

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

BlackRock Advisors's BTX.WS Position: Q3 2016 in Review

BlackRock Advisors sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q3 2016, closing a stake of 49,256 shares — an estimated $23K sold.

BlackRock Advisors first reported a position in BTX.WS in Q2 2015 and held it in 5 quarters. The position peaked at $64K in Q4 2015. 35 funds tracked by Wall St. Rank hold BTX.WS as of Q3 2016.

BlackRock Advisors reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q3 2016 after selling out during the quarter.
BlackRock Advisors sold 49,256 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q3 2016, an estimated $23K.
BlackRock Advisors first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q2 2015 and held it in 5 quarters.
BlackRock Advisors's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $64K in Q4 2015.
35 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q3 2016.

Based on BlackRock Advisors's 13F filing for Q3 2016, filed 8 Nov 2016.